The following IP precedent provides comprehensive and up to date legal information covering:
Letter of claim—patent infringement
[Alleged infringer’s name and address]
Dear [insert organisation name]
We are writing on behalf of [name and address of client] (‘our client’). We are writing to you about your activities and actions.
Our client is the [owner OR assignee OR exclusive licensee] of [GB Patent number [add patent number] OR EP(UK) Patent number [add patent number]], a copy of which is enclosed for your information (the ‘Patent’).
It has come to our client’s attention that [name of alleged infringing company] [is OR appears to be] [making and/or importing [description of allegedly infringing product] (the Product) OR using a process covered by this patent [description of allegedly infringing process] (the Process)], at least since [insert earliest date of evidence available to you so far, eg date of printing website/date of an invoice or receipt for a test purchase]. A sample Product [is enclosed with this letter OR is available for inspection at our offices OR may be viewed at url: [insert url] (print-outs of the relevant webpages are enclosed) OR is contained in the enclosed copy brochure OR may be viewed in the enclosed photograph].
Our client has not consented to [alleged infringing company name]’s [making and/or importation of this Product OR using the Process]. [Such unauthorised making and/or importation OR use of the Process]
**Trials are provided to all LexisPSL and LexisLibrary content, excluding Practice Compliance, Practice Management and Risk and Compliance, subscription packages are tailored to your specific needs. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Take a free trial
Coronavirus (COVID-19): The guidance detailing normal practice set out in this Practice Note may be affected by measures concerning process and procedure in the civil courts that have been introduced as a result of the coronavirus (COVID-19) pandemic. For guidance, see Practice Note: Coronavirus
This Practice Note provides guidance on the interpretation and application of the relevant provisions of the CPR. Depending on the court in which your matter is proceeding, you may also need to be mindful of additional provisions—see further below.You should also consider if the proceedings will be
The roles of nominated officer and money laundering reporting officerA nominated officer is an individual who is nominated by a firm to receive disclosures under Part 7 of the Proceeds of Crime Act 2002 (POCA 2002) or Part III of the Terrorism Act 2000 (TA 2000)—see Requirement to appoint a
This Practice Note provides guidance on the SRA Codes of Conduct, contained in the SRA Standards and Regulations, in force from 25 November 2019. The SRA Standards and Regulations include two Codes of Conduct—a Code forSolicitors, RELs and RFLs and a Code for Firms. The Standards and Regulations
0330 161 1234
To view our latest legal guidance content,sign-in to Lexis®PSL or register for a free trial.